“The demand for drugs, vaccines and diagnostic tools is in Italy, but also in other countries, mainly a public demand supported by the national health system. The Government believes that a global reflection should be opened between institutions and companies in Italy, to define a review of the regulatory and financing system for public demand for pharmaceutical products and of the rules governing their marketing and setting their prices, in order to make the attraction of investments compatible with the sustainability of the national health system “. This was stated by Giancarlo Giorgetti, Minister of Economic Development, opening the event ‘InnovaCtion, what is needed for ideas to become health, business, future’, promoted by GlaxoSmithKline (Gsk) at its headquarters in Verona, on the occasion of the 90th anniversary of presence of the company in our country.
“The dialogue undertaken with your company, and with other important pharmaceutical companies operating on a global level, is important for the regulatory innovation that we want to pursue and also for defining virtuous collaborations and encouraging investments in innovation in our country”, Giorgetti underlined according to whom we must and can “seek greater convergence of the regulatory systems of the pharmaceutical market within the Member States of the Union”. (continues)
#Giorgetti #Government #reflection #revision #drug #system